Itraconazole and Ranolazine Interaction

Drug interaction information between Itraconazole and Ranolazine.

Itraconazole and Ranolazine have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Itraconazole and Ranolazine. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Itraconazole

Azole Antifungal

Drug B

Ranolazine

Late Sodium Current Inhibitor (Antianginal)

How They Interact

Itraconazole blocks the enzymes that break down ranolazine, which can cause the heart medicine to reach dangerous levels in your body.

FDA Label Information

Cardiovascular Drugs, Miscellaneous Ivabradine Ranolazine Contraindicated during and 2 weeks after itraconazole treatment.

Frequently Asked Questions

What SPL severity band is on file for Itraconazole + Ranolazine?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Itraconazole has 116 labeled pairs on file vs Ranolazine's 31. In the major band specifically: Itraconazole has 19 (also Isavuconazonium, Lurasidone, Pimozide, Methadone); Ranolazine has 12 (also Ketoconazole, Carbamazepine, Clarithromycin, Rifampin).

What mechanism field is on file for Itraconazole and Ranolazine?

Itraconazole blocks the enzymes that break down ranolazine, which can cause the heart medicine to reach dangerous levels in your body.

Itraconazole carries more major-labeled pairs than Ranolazine

SPL source-record counts only. This page's band is major · classes on file: Itraconazole (Azole Antifungal); Ranolazine (Late Sodium Current Inhibitor (Antianginal)).

Itraconazole has 19 major-labeled pairs vs Ranolazine's 12.

Itraconazole

19 major · 20 moderate · 77 minor · 116 total

Ranolazine

12 major · 7 moderate · 12 minor · 31 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.